Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Sci-Tech Press Iceland.
Wiggle Butt Academy Welcomes Rhea Northcut, CPDT-KA, CSAT, FDM — A Certified Expert in Separation Anxiety Training
EIN Presswire
·
May 12, 2025
Wiggle Butt Academy, a leader in science-based, positive reinforcement training, is proud to announce the addition of Rhea Northcut to the team. TX, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- Wiggle Butt Academy, a leader in...
UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab)
GlobeNewswire, Inc.
·
March 26, 2025
REYKJAVIK, Iceland, PISCATAWAY, N.J. and LONDON, March 26, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv...
Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer
GlobeNewswire, Inc.
·
March 27, 2025
REYKJAVIK, Iceland, March 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the...
DRML Miner Launches Free Crypto Cloud Mining with USDC Payouts—A Game-Changing Opportunity for Passive Income
GlobeNewswire, Inc.
·
June 25, 2025
London, UK, June 25, 2025 (GLOBE NEWSWIRE) -- In a bold move that’s reshaping how everyday users approach crypto mining, DRML Miner has officially launched a new phase of its cloud mining platform—offering free, no-cost mining access to Bitcoin...
Oculis Reports Q1 2025 Financial Results and Provides Company Update
GlobeNewswire, Inc.
·
May 8, 2025
The recent R&D Day (replay) showcased material progress across all three core assets and highlighted potential first-in-class neuroprotection treatment in neuro-ophthalmology, an area of high unmet medical need, thanks to Privosegtor’s (OCS-05)...
Oculis Publishes Invitation to the Annual General Meeting
GlobeNewswire, Inc.
·
May 9, 2025
ZUG, Switzerland, May 09, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), today published the invitation to the 2025 Annual General Meeting, which will be held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11,...
Tourism Source Market Poised to Reach US$ 1.1 Trillion by 2032 with a 6.6% CAGR
EIN Presswire
·
June 25, 2025
By tourist type, the group segment dominated the global market and is likely to remain dominant during the forecast period. WILMINGTON, DE, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- The Tourism Source Market Size was valued at $599.40...
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
GlobeNewswire, Inc.
·
May 5, 2025
The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April 30, 2025 SELARSDI is approved for all...
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
GlobeNewswire, Inc.
·
May 5, 2025
The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April 30, 2025 SELARSDI is approved for all...
Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production
GlobeNewswire, Inc.
·
March 20, 2025
REYKJAVIK, Iceland and STOCKHOLM, March 20, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the acquisition...
Basilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025
GlobeNewswire, Inc.
·
April 16, 2025
Allschwil, Switzerland, April 16, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today...
Oculis to Present at Upcoming May Investor Conferences
GlobeNewswire, Inc.
·
May 7, 2025
ZUG, Switzerland, May 07, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet...
Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conferences
GlobeNewswire, Inc.
·
May 1, 2025
ZUG, Switzerland, May 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet...
United Kingdom Falls to 12th Spot in 2025 World Citizenship Index, as Switzerland Claims Top Rank
EIN Presswire
·
June 23, 2025
LONDON, UNITED KINGDOM, June 23, 2025 /EINPresswire.com/ -- The United Kingdom has secured the 12th position in the 2025 World Citizenship Index (WCI), released by CS Global Partners in their much-anticipated annual World Citizenship Report....
A Compliant and Secure Global Cloud Mining Platform Launches New Short-Term Contracts and Free Mining Opportunities
GlobeNewswire, Inc.
·
May 27, 2025
Greater Manchester, England, May 27, 2025 (GLOBE NEWSWIRE) -- I. Company profile: Cloud Mining was founded in May 2019 and is headquartered in the UK. Advanced (Application-Specific Integrated Circuit) technology, 180+ blockchain industry and IT...
Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida
GlobeNewswire, Inc.
·
March 7, 2025
REYKJAVIK, Iceland, March 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Barclays...
argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
GlobeNewswire, Inc.
·
April 28, 2025
VYVGART® is first-and-only targeted IgG Fc-antibody fragment for CIDP First novel mechanism of action for CIDP treatment in more than 30 years CHMP positive opinion based on ADHERE data, the largest ever CIDP clinical trial European Commission...
Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award
GlobeNewswire, Inc.
·
April 17, 2025
ZUG, Switzerland, April 17, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet...
Seaweed Market Worth Observing Growth Rate of 9.5% from 2025 to 2034 | Annie Chun's, Inc., Brandt, Inc., Cargill
EIN Presswire
·
June 17, 2025
WILMINGTON, DE, UNITED STATES, June 17, 2025 /EINPresswire.com/ -- The seaweed market size was valued at $7.5 billion in 2024, and is estimated to reach $18.1 billion by 2034, growing at a CAGR of 9.5% from 2025 to 2034. Seaweed is a diverse...
2024 Full Year Financial Results
GlobeNewswire, Inc.
·
March 28, 2025
Reykjavík, March 28, 2025 (GLOBE NEWSWIRE) -- ("Amaroq" or the "Company") 2024 Full Year Financial Results 2024 - a pivotal year marking the transition from developer to producer at our flagship Nalunaq mine TORONTO, ONTARIO – 28 March 2025 –...